Carla Maciag

797 total citations
14 papers, 605 citations indexed

About

Carla Maciag is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Carla Maciag has authored 14 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Carla Maciag's work include Neuroscience and Neuropharmacology Research (5 papers), Stress Responses and Cortisol (3 papers) and Receptor Mechanisms and Signaling (3 papers). Carla Maciag is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Stress Responses and Cortisol (3 papers) and Receptor Mechanisms and Signaling (3 papers). Carla Maciag collaborates with scholars based in United States, Sweden and Puerto Rico. Carla Maciag's co-authors include Robert Zaczek, Richard A. Earl, Robert J. Chorvat, Maria Pierdomenico, J Saye, David H. Rominger, Thomas J. Hudzik, James Doherty, Dan Widzowski and John Gordon and has published in prestigious journals such as Journal of Neurophysiology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Carla Maciag

14 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carla Maciag United States	12	351	319	126	86	82	14	605
Lucinda J. Steward United Kingdom	17	502 1.4×	536 1.7×	43 0.3×	66 0.8×	101 1.2×	25	903
Daniela Pechlivanova Bulgaria	13	144 0.4×	272 0.9×	60 0.5×	50 0.6×	67 0.8×	38	561
Linda Ferrington United Kingdom	12	130 0.4×	188 0.6×	48 0.4×	115 1.3×	44 0.5×	22	464
Sven Akkerman Netherlands	9	293 0.8×	183 0.6×	87 0.7×	179 2.1×	37 0.5×	9	617
Jane Gartlon United Kingdom	13	243 0.7×	306 1.0×	30 0.2×	101 1.2×	41 0.5×	18	628
Shawn Gouty United States	14	271 0.8×	256 0.8×	81 0.6×	35 0.4×	24 0.3×	24	565
Deborah K. Hyslop United States	12	324 0.9×	515 1.6×	53 0.4×	142 1.7×	32 0.4×	19	900
Naheed Mirza Denmark	19	508 1.4×	486 1.5×	45 0.4×	80 0.9×	46 0.6×	24	857
Steven M. Grauer United States	11	524 1.5×	357 1.1×	44 0.3×	171 2.0×	30 0.4×	14	788
Daniel Dlaboga Poland	11	278 0.8×	186 0.6×	34 0.3×	154 1.8×	42 0.5×	16	462

Countries citing papers authored by Carla Maciag

Since Specialization

Citations

This map shows the geographic impact of Carla Maciag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Maciag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Maciag more than expected).

Fields of papers citing papers by Carla Maciag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Maciag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Maciag. The network helps show where Carla Maciag may publish in the future.

Co-authorship network of co-authors of Carla Maciag

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Maciag. A scholar is included among the top collaborators of Carla Maciag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Maciag. Carla Maciag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hammond, Rebecca, Alison L. Althaus, Michael A. Ackley, et al.. (2017). Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models. Epilepsy Research. 134. 16–25. 19 indexed citations

Richards, Erica M., Daniel C. Mathews, David A. Luckenbaugh, et al.. (2016). A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology. 233(6). 1119–1130. 59 indexed citations

Cross, A.J., Dan Widzowski, Carla Maciag, et al.. (2015). Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models. British Journal of Pharmacology. 173(1). 155–166. 30 indexed citations

Christian, Edward P., Wei Song, David Gurley, et al.. (2014). EEG-β/γ spectral power elevation in rat: a translatable biomarker elicited by GABA_Aα2/3-positive allosteric modulators at nonsedating anxiolytic doses. Journal of Neurophysiology. 113(1). 116–131. 57 indexed citations

Peters, Matthew F., Anna Zacco, John Gordon, et al.. (2011). Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity. European Journal of Pharmacology. 661(1-3). 27–34. 44 indexed citations

Hudzik, Thomas J., Carla Maciag, Mark A. Smith, et al.. (2011). Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor. Journal of Pharmacology and Experimental Therapeutics. 338(1). 195–204. 44 indexed citations

Sydserff, S G, Dekun Song, Michael C. Quirk, et al.. (2009). Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes. Biochemical Pharmacology. 78(7). 880–888. 81 indexed citations

Hudzik, Thomas J., Jian Zhou, Becky Brockel, et al.. (2008). P.2.d.012 Further characterization of norquetiapine and quetiapine in rodent models of antidepressant and anxiolytic action. European Neuropsychopharmacology. 18. S351–S352. 5 indexed citations

Maciag, Carla, et al.. (2007). P.2.h.004 Anxiolytic effects of quetiapine in rat punished responding: mechanism of action and the role of D2 antagonism. European Neuropsychopharmacology. 17. S399–S400. 2 indexed citations

10.

Maciag, Carla. (2002). Effects of a Non-peptide CRF Antagonist (DMP696) on the Behavioral and Endocrine Sequelae of Maternal Separation. Neuropsychopharmacology. 26(5). 574–582. 44 indexed citations

11.

Ho, Siew Peng, Lorey K. Takahashi, Carla Maciag, et al.. (2001). Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Molecular Brain Research. 89(1-2). 29–40. 64 indexed citations

12.

Zaczek, Robert, Robert J. Chorvat, J Saye, et al.. (1998). Two New Potent Neurotransmitter Release Enhancers, 10,10-Bis(4-Pyridinylmethyl)-9(10H)-Anthracenone and 10,10-Bis(2-Fluoro-4-Pyridinylmethyl)-9(10H)-Anthracenone: Comparison to Linopirdine. Journal of Pharmacology and Experimental Therapeutics. 285(2). 724–730. 115 indexed citations

13.

Earl, Richard A., Robert Zaczek, Christopher A. Teleha, et al.. (1998). 2-Fluoro-4-pyridinylmethyl Analogues of Linopirdine as Orally Active Acetylcholine Release-Enhancing Agents with Good Efficacy and Duration of Action. Journal of Medicinal Chemistry. 41(23). 4615–4622. 25 indexed citations

14.

Maciag, Carla, et al.. (1994). Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 891–897. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact